Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Sector movers: Defensive pharma stocks fall as Santa Rally continues

Tue, 23rd Dec 2014 16:18

Pharmaceutical and healthcare stocks were leading the fallers on Tuesday as investors dumped defensive assets amid a continued pre-Christmas rally.UK stocks have risen for six straight days as markets rebounded strongly following a recent sell-off.While more cyclical sectors such as construction and mining have performed well, shares in the defensive categories have taken the brunt of investors taking on more risk.Medical-device maker Smith & Nephew was among the worst performers on the FTSE 100 in afternoon trade, followed closely behind by pharma giants Astrazeneca and Shire.Glaxosmithkline and Hikma Pharmaceuticals were also trading in the red. Top performing sectors so far todayIndustrial Metals & Mining 1,475.34 +4.98%Oil Equipment, Services & Distribution 17,010.02 +2.54%Construction & Materials 4,128.05 +2.35%Industrial Engineering 8,991.97 +1.99%Food & Drug Retailers 2,778.65 +1.92%Bottom performing sectors so far todayPharmaceuticals & Biotechnology 12,688.15 -1.63%Health Care Equipment & Services 6,276.94 -1.58%Tobacco 40,887.31 -0.44%Food Producers & Processors 8,253.65 -0.14%Software & Computer Services 1,240.78 -0.14%

Related Shares

More News
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...

Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was ...

7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.